Search research articles
Contact Us
Filters
Showing results (111-120 of 140) with videos related to
Page
of 14
Sort By:
The American Journal of Psychiatry
|
March 3, 2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study
Marvin S Swartz, Diana O Perkins, T Scott Stroup, et al.
Schizophrenia Research
|
February 9, 2008
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1
Jonathan M Meyer, Vicki G Davis, Donald C Goff, et al.
The American Journal of Psychiatry
|
December 8, 2006
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia
Robert A Rosenheck, Douglas L Leslie, Jody Sindelar, et al.
PLOS Mental Health
|
September 2, 2025
Mental disorders and criminal legal involvement: Evidence from a national diagnostic epidemiological survey
Jeffrey W Swanson, Madeline Stenger, Michele M Easter, et al.
The New England Journal of Medicine
|
September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
Jeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease
|
March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study
Marvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Schizophrenia Research
|
January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study
Marvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Psychiatric Services (Washington, D.C.)
|
September 23, 2024
Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study
Natalie Bareis, Mark Edlund, Heather Ringeisen, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trial
Del D Miller, Stanley N Caroff, Sonia M Davis, et al.
The American Journal of Psychiatry
|
April 6, 2006
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
Joseph P McEvoy, Jeffrey A Lieberman, T Scott Stroup, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 140) with videos related to
Sort By:
Page
of 14
The American Journal of Psychiatry
|
March 3, 2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study
Marvin S Swartz, Diana O Perkins, T Scott Stroup, et al.
Schizophrenia Research
|
February 9, 2008
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1
Jonathan M Meyer, Vicki G Davis, Donald C Goff, et al.
The American Journal of Psychiatry
|
December 8, 2006
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia
Robert A Rosenheck, Douglas L Leslie, Jody Sindelar, et al.
PLOS Mental Health
|
September 2, 2025
Mental disorders and criminal legal involvement: Evidence from a national diagnostic epidemiological survey
Jeffrey W Swanson, Madeline Stenger, Michele M Easter, et al.
The New England Journal of Medicine
|
September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
Jeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease
|
March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study
Marvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Schizophrenia Research
|
January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study
Marvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Psychiatric Services (Washington, D.C.)
|
September 23, 2024
Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study
Natalie Bareis, Mark Edlund, Heather Ringeisen, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trial
Del D Miller, Stanley N Caroff, Sonia M Davis, et al.
The American Journal of Psychiatry
|
April 6, 2006
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
Joseph P McEvoy, Jeffrey A Lieberman, T Scott Stroup, et al.
Page
of 14